Literature DB >> 15388475

Resistance phenotypes and genotypes of erythromycin-resistant Streptococcus pneumoniae isolates in Beijing and Shenyang, China.

Zhao Tiemei1, Fang Xiangqun, Liu Youning.   

Abstract

Of a total of 192 Streptococcus pneumoniae isolates, 149 (77.6%) were not susceptible to erythromycin. Of these 149 isolates, 117 (79.1%) contained the erm(B) gene, 16 (10.8%) contained the mef(A) gene, and 15 (10.1%) harbored both the erm(B) and mef(A) genes.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15388475      PMCID： PMC521870          DOI： 10.1128/AAC.48.10.4040-4041.2004

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  17 in total

1.  Prevalence of macrolide resistance mechanisms in Streptococcus pneumoniae isolates from a multicenter antibiotic resistance surveillance study conducted in the United States in 1994-1995.

Authors:  V D Shortridge; G V Doern; A B Brueggemann; J M Beyer; R K Flamm
Journal:  Clin Infect Dis       Date:  1999-11       Impact factor: 9.079

2.  Serotype 19f multiresistant pneumococcal clone harboring two erythromycin resistance determinants (erm(B) and mef(A)) in South Africa.

Authors:  L McGee; K P Klugman; A Wasas; T Capper; A Brink
Journal:  Antimicrob Agents Chemother       Date:  2001-05       Impact factor: 5.191

Review 3.  Intrinsic and unusual resistance to macrolide, lincosamide, and streptogramin antibiotics in bacteria.

Authors:  R Leclercq; P Courvalin
Journal:  Antimicrob Agents Chemother       Date:  1991-07       Impact factor: 5.191

4.  Macrolide efflux genes mef(A) and mef(E) are carried by different genetic elements in Streptococcus pneumoniae.

Authors:  M Del Grosso; F Iannelli; C Messina; M Santagati; N Petrosillo; S Stefani; G Pozzi; A Pantosti
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

5.  Macrolide resistance mechanisms and expression of phenotypes among Streptococcus pneumoniae circulating in Italy.

Authors:  A Marchese; E Tonoli; E A Debbia; G C Schito
Journal:  J Antimicrob Chemother       Date:  1999-10       Impact factor: 5.790

6.  In vitro activity of telithromycin against Spanish Streptococcus pneumoniae isolates with characterized macrolide resistance mechanisms.

Authors:  M I Morosini; R Cantón; E Loza; M C Negri; J C Galán; F Almaraz; F Baquero
Journal:  Antimicrob Agents Chemother       Date:  2001-09       Impact factor: 5.191

7.  Increasing resistance of Streptococcus pneumoniae to fluoroquinolones: results of a Hong Kong multicentre study in 2000.

Authors:  P L Ho; R W Yung; D N Tsang; T L Que; M Ho; W H Seto; T K Ng; W C Yam; W W Ng
Journal:  J Antimicrob Chemother       Date:  2001-11       Impact factor: 5.790

8.  Identification of an erm(A) erythromycin resistance methylase gene in Streptococcus pneumoniae isolated in Greece.

Authors:  G A Syrogiannopoulos; I N Grivea; A Tait-Kamradt; G D Katopodis; N G Beratis; J Sutcliffe; P C Appelbaum; T A Davies
Journal:  Antimicrob Agents Chemother       Date:  2001-01       Impact factor: 5.191

9.  Antimicrobial susceptibilities of 1,684 Streptococcus pneumoniae and 2,039 Streptococcus pyogenes isolates and their ecological relationships: results of a 1-year (1998-1999) multicenter surveillance study in Spain.

Authors:  E Pérez-Trallero; C Fernández-Mazarrasa; C García-Rey; E Bouza; L Aguilar; J García-de-Lomas; F Baquero
Journal:  Antimicrob Agents Chemother       Date:  2001-12       Impact factor: 5.191

10.  Clinical and molecular epidemiology of erythromycin-resistant beta-hemolytic lancefield group G streptococci causing bacteremia.

Authors:  Patrick C Y Woo; Amanda P C To; Herman Tse; Susanna K P Lau; Kwok-Yung Yuen
Journal:  J Clin Microbiol       Date:  2003-11       Impact factor: 5.948
View more
  5 in total

1.  Different microbiological and clinical aspects of lower respiratory tract infections between China and European/American countries.

Authors:  Xin Zhang; Rui Wang; Xiuzhen Di; Bin Liu; Youning Liu
Journal:  J Thorac Dis       Date:  2014-02       Impact factor: 2.895

Review 2.  Antibiotic resistance amongst healthcare-associated pathogens in China.

Authors:  Saber Yezli; Han Li
Journal:  Int J Antimicrob Agents       Date:  2012-09-20       Impact factor: 5.283

3.  Antimicrobial Resistance Trends of the Most Common Causative Pathogens Associated with Community-acquired Respiratory Infections in China: 2009-2018.

Authors:  Chunjiang Zhao; Shuo Yang; Feifei Zhang; Zhanwei Wang; Yawei Zhang; Xiaojuan Wang; Henan Li; Hongbin Chen; Hui Wang
Journal:  Infect Drug Resist       Date:  2022-08-31       Impact factor: 4.177

4.  Global fluoroquinolone resistance epidemiology and implictions for clinical use.

Authors:  Axel Dalhoff
Journal:  Interdiscip Perspect Infect Dis       Date:  2012-10-14

5.  Causative agent distribution and antibiotic therapy assessment among adult patients with community acquired pneumonia in Chinese urban population.

Authors:  Youning Liu; Minjun Chen; Tiemei Zhao; Hui Wang; Rui Wang; Baiqiang Cai; Bin Cao; Tieying Sun; Yunjian Hu; Qingyu Xiu; Xin Zhou; Xing Ding; Lan Yang; Jiansheng Zhuo; Yingchun Tang; Kouxing Zhang; Derong Liang; Xiaoju Lv; Shengqi Li; Yong Liu; Yunsong Yu; Zeqing Wei; Kejing Ying; Feng Zhao; Ping Chen; Xiaona Hou
Journal:  BMC Infect Dis       Date:  2009-03-18       Impact factor: 3.090
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.